28/06/2017 - 05:55

PharmAust engages Canadian specialist to improve taste of Cancer drug

28/06/2017 - 05:55


Upgrade your subscription to use this feature.

PharmAust has engaged Canadian pharmaceutical specialist BRI to reformulate its promising anti-cancer drug Monepantel in readiness for more clinical trials and commercialisation. Monepantel has already shown positive outcomes treating cancer and PharmAust are now looking to improve the taste profile and palatability of the drug.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options